메뉴 건너뛰기




Volumn 182, Issue , 2014, Pages 53-61

The consequences of implementing non-invasive prenatal testing in Dutch national health care: A cost-effectiveness analysis

Author keywords

Cost effectiveness analysis; Detection rate; Non invasive prenatal testing; Prenatal screening; Trisomy 21

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; NETHERLANDS; NON INVASIVE PRENATAL TESTING; PREGNANCY; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; PROCEDURE RELATED MISCARRIAGE; PUBLIC HEALTH SERVICE; SCREENING TEST; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; TRISOMY 21; ABORTION, SPONTANEOUS; ADVERSE EFFECTS; AMNIOCENTESIS; ANEUPLOIDY; BLOOD; CHORION VILLUS SAMPLING; COST BENEFIT ANALYSIS; DECISION TREE; DOWN SYNDROME; ECONOMICS; FETUS ECHOGRAPHY; GENETIC SCREENING; HEALTH CARE POLICY; PRENATAL DIAGNOSIS; PROCEDURES; RISK FACTOR;

EID: 84920646237     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2014.08.028     Document Type: Article
Times cited : (52)

References (38)
  • 1
    • 0342618532 scopus 로고    scopus 로고
    • Presence of fetal DNA in maternal plasma and serum
    • Y.M.D. Lo, N. Corbetta, and P.F. Chamberlain Presence of fetal DNA in maternal plasma and serum Lancet 350 1997 485 487
    • (1997) Lancet , vol.350 , pp. 485-487
    • Lo, Y.M.D.1    Corbetta, N.2    Chamberlain, P.F.3
  • 2
    • 58149490683 scopus 로고    scopus 로고
    • Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma
    • R.W.K. Chiu, K.C.A. Chan, and Y. Gao Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma Proc Natl Acad Sci USA 105 2008 20458 20463
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 20458-20463
    • Chiu, R.W.K.1    Chan, K.C.A.2    Gao, Y.3
  • 3
    • 55849124028 scopus 로고    scopus 로고
    • Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
    • H.C. Fan, Y.J. Blumenfeld, and U. Chitkara Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood Proc Natl Acad Sci USA 105 2008 16266 16271
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 16266-16271
    • Fan, H.C.1    Blumenfeld, Y.J.2    Chitkara, U.3
  • 4
    • 84859320067 scopus 로고    scopus 로고
    • Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18
    • G. Ashoor, A. Syngelaki, M. Wagner, C. Birdir, and K.H. Nicolaides Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18 Am J Obstet Gynecol 206 2012 322.e1 322.e5
    • (2012) Am J Obstet Gynecol , vol.206 , pp. 322e1-322e5
    • Ashoor, G.1    Syngelaki, A.2    Wagner, M.3    Birdir, C.4    Nicolaides, K.H.5
  • 6
    • 84896691791 scopus 로고    scopus 로고
    • DNA sequencing versus standard prenatal aneuploidy screening
    • D.W. Bianchi, R.L. Parker, and J. Wentworth DNA sequencing versus standard prenatal aneuploidy screening N Engl J Med 370 2014 799 808
    • (2014) N Engl J Med , vol.370 , pp. 799-808
    • Bianchi, D.W.1    Parker, R.L.2    Wentworth, J.3
  • 7
    • 84870688045 scopus 로고    scopus 로고
    • Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors
    • S. Dan, W. Wang, and J. Ren Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors Prenat Diagn 32 2012 1225 1232
    • (2012) Prenat Diagn , vol.32 , pp. 1225-1232
    • Dan, S.1    Wang, W.2    Ren, J.3
  • 8
    • 79952302397 scopus 로고    scopus 로고
    • Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting
    • M. Ehrich, C. Deciu, and T. Zwiefelhofer Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting Am J Obstet Gynecol 204 2011 205.e1 205.e11
    • (2011) Am J Obstet Gynecol , vol.204 , pp. 205e1-205e11
    • Ehrich, M.1    Deciu, C.2    Zwiefelhofer, T.3
  • 9
    • 84868029481 scopus 로고    scopus 로고
    • Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
    • K.H. Nicolaides, A. Syngelaki, G. Ashoor, C. Birdir, and G. Touzet Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population Am J Obstet Gynecol 207 2012 374.e1 374.e6
    • (2012) Am J Obstet Gynecol , vol.207 , pp. 374e1-374e6
    • Nicolaides, K.H.1    Syngelaki, A.2    Ashoor, G.3    Birdir, C.4    Touzet, G.5
  • 10
    • 84864408781 scopus 로고    scopus 로고
    • Non-invasive chromosomal evaluation (NICE) study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
    • M.E. Norton, H. Brar, and J. Weiss Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 Am J Obstet Gynecol 207 2012 137.e1 137.e8
    • (2012) Am J Obstet Gynecol , vol.207 , pp. 137e1-137e8
    • Norton, M.E.1    Brar, H.2    Weiss, J.3
  • 11
    • 80755172331 scopus 로고    scopus 로고
    • DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
    • G.E. Palomaki, E.M. Kloza, and G.M. Lambert-Messerlian DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet Med 13 2011 913 920
    • (2011) Genet Med , vol.13 , pp. 913-920
    • Palomaki, G.E.1    Kloza, E.M.2    Lambert-Messerlian, G.M.3
  • 12
    • 70749129616 scopus 로고    scopus 로고
    • Centraal Bureau voor de Statistiek (CBS) [retrieved 11.02.13]
    • Centraal Bureau voor de Statistiek (CBS), Statistics Netherlands. Available at http://statline.cbs.nl [retrieved 11.02.13].
    • Statistics Netherlands
  • 14
    • 0036227897 scopus 로고    scopus 로고
    • Revised estimates of the maternal age specific live birth prevalence of Down's syndrome
    • J.K. Morris, D.E. Mutton, and E. Alberman Revised estimates of the maternal age specific live birth prevalence of Down's syndrome J Med Screen 9 2002 2 6
    • (2002) J Med Screen , vol.9 , pp. 2-6
    • Morris, J.K.1    Mutton, D.E.2    Alberman, E.3
  • 15
    • 0025899530 scopus 로고
    • Amniocentesis or chorionic villus sampling for prenatal genetic testing: A decision analysis
    • P.S. Heckerling, and M.S. Verp Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis J Clin Epidemiol 44 1991 657 670
    • (1991) J Clin Epidemiol , vol.44 , pp. 657-670
    • Heckerling, P.S.1    Verp, M.S.2
  • 16
    • 84875658488 scopus 로고    scopus 로고
    • Factors determining uptake of invasive testing following first-trimester combined testing
    • K.D. Lichtenbelt, G. Heleen Schuring-Blom, and N. van der Burg Factors determining uptake of invasive testing following first-trimester combined testing Prenat Diagn 33 2013 328 333
    • (2013) Prenat Diagn , vol.33 , pp. 328-333
    • Lichtenbelt, K.D.1    Heleen Schuring-Blom, G.2    Van Der Burg, N.3
  • 17
    • 0032480524 scopus 로고    scopus 로고
    • Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales, 1989-97
    • D. Mutton, R.G. Ide, and E. Alberman Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales, 1989-97 BMJ 317 1998 922 923
    • (1998) BMJ , vol.317 , pp. 922-923
    • Mutton, D.1    Ide, R.G.2    Alberman, E.3
  • 18
    • 71249104673 scopus 로고    scopus 로고
    • Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: Analysis of data from the National Down Syndrome Cytogenetic Register
    • J.K. Morris, and E. Alberman Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register BMJ 339 2009 b3794
    • (2009) BMJ , vol.339 , pp. b3794
    • Morris, J.K.1    Alberman, E.2
  • 19
    • 70350503181 scopus 로고    scopus 로고
    • Diagnostic performance of routine ultrasound screening for fetal abnormalities in an unselected Swedisch population in 2000-2005
    • G. Romosan, E. Henriksson, A. Rylander, and L. Valentin Diagnostic performance of routine ultrasound screening for fetal abnormalities in an unselected Swedisch population in 2000-2005 Ultrasound Obstet Gynecol 34 2009 526 533
    • (2009) Ultrasound Obstet Gynecol , vol.34 , pp. 526-533
    • Romosan, G.1    Henriksson, E.2    Rylander, A.3    Valentin, L.4
  • 20
    • 67650258731 scopus 로고    scopus 로고
    • Fetal loss rate after chorionic villus sampling and amniocentesis: An 11-year national registry study
    • A. Tabor, C.H.F. Vestergaard, and O. Lidegaard Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study Ultrasound Obstet Gynaecol 34 2009 19 24
    • (2009) Ultrasound Obstet Gynaecol , vol.34 , pp. 19-24
    • Tabor, A.1    Vestergaard, C.H.F.2    Lidegaard, O.3
  • 21
    • 79952777513 scopus 로고    scopus 로고
    • Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in the Netherlands
    • G. de Graaf, M. Haveman, and R. Hochstenbach Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in the Netherlands J Intell Disability Res 55 2011 462 473
    • (2011) J Intell Disability Res , vol.55 , pp. 462-473
    • De Graaf, G.1    Haveman, M.2    Hochstenbach, R.3
  • 22
    • 78650803485 scopus 로고    scopus 로고
    • Screening for fetal aneuploidies at 11 to 13 weeks
    • K.H. Nicolaides Screening for fetal aneuploidies at 11 to 13 weeks Prenat Diagn 31 2011 7 15
    • (2011) Prenat Diagn , vol.31 , pp. 7-15
    • Nicolaides, K.H.1
  • 23
    • 82255192321 scopus 로고    scopus 로고
    • Performance of first-trimester combined test for Down syndrome in different maternal age groups: Reasons for adjustments in screening policy
    • M.A. Engels, A.C. Heijboer, M.A. Blankenstein, and J.M.G. van Vugt Performance of first-trimester combined test for Down syndrome in different maternal age groups: reasons for adjustments in screening policy Prenat Diagn 13 2011 1241 1245
    • (2011) Prenat Diagn , vol.13 , pp. 1241-1245
    • Engels, M.A.1    Heijboer, A.C.2    Blankenstein, M.A.3    Van Vugt, J.M.G.4
  • 24
    • 0032517538 scopus 로고    scopus 로고
    • 6-year experience of prenatal diagnosis in an unselected population in Oxford, UK
    • P.A. Boyd, P. Chamberlain, and N.R. Hicks 6-year experience of prenatal diagnosis in an unselected population in Oxford, UK Lancet 352 1998 1577 1581
    • (1998) Lancet , vol.352 , pp. 1577-1581
    • Boyd, P.A.1    Chamberlain, P.2    Hicks, N.R.3
  • 28
    • 84875636811 scopus 로고    scopus 로고
    • Changing attitudes towards termination of pregnancy for trisomy 21 with non-invasive prenatal trisomy testing: A population-based study in Dutch pregnant women
    • E.J. Verweij, D. Oepkes, and M.A. de Boer Changing attitudes towards termination of pregnancy for trisomy 21 with non-invasive prenatal trisomy testing: a population-based study in Dutch pregnant women Prenat Diagn 33 2013 397 399
    • (2013) Prenat Diagn , vol.33 , pp. 397-399
    • Verweij, E.J.1    Oepkes, D.2    De Boer, M.A.3
  • 29
    • 82255192286 scopus 로고    scopus 로고
    • Noninvasive prenatal diagnosis: Pregnant women's interest and expected uptake
    • R. Tischler, L. Hudgins, Y.J. Blumenfeld, H.T. Greely, and K.E. Ormond Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake Prenat Diagn 31 2011 1292 1299
    • (2011) Prenat Diagn , vol.31 , pp. 1292-1299
    • Tischler, R.1    Hudgins, L.2    Blumenfeld, Y.J.3    Greely, H.T.4    Ormond, K.E.5
  • 30
    • 84896767667 scopus 로고    scopus 로고
    • NIPT in a clinical setting: An analysis of uptake in the first months of clinical availability
    • J.B. Taylor, V.Y. Chock, and L. Hudgins NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability J Genet Counsel 23 2014 72 78
    • (2014) J Genet Counsel , vol.23 , pp. 72-78
    • Taylor, J.B.1    Chock, V.Y.2    Hudgins, L.3
  • 31
    • 84878125815 scopus 로고    scopus 로고
    • Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
    • S. Chetty, M.J. Garabedian, and M.E. Norton Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening Prenat Diagn 33 2013 542 546
    • (2013) Prenat Diagn , vol.33 , pp. 542-546
    • Chetty, S.1    Garabedian, M.J.2    Norton, M.E.3
  • 32
    • 84880304596 scopus 로고    scopus 로고
    • Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population
    • K. Song, T.J. Musci, and A.B. Caughey Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population J Matern Fetal Neonatal Med 26 2013 1180 1185
    • (2013) J Matern Fetal Neonatal Med , vol.26 , pp. 1180-1185
    • Song, K.1    Musci, T.J.2    Caughey, A.B.3
  • 33
    • 84880039807 scopus 로고    scopus 로고
    • The role of noninvasive prenatal testing as a diagnostic versus a screening tool - A cost-effectiveness analysis
    • M. Ohno, and A. Caughey The role of noninvasive prenatal testing as a diagnostic versus a screening tool - a cost-effectiveness analysis Prenat Diagn 33 2013 630 635
    • (2013) Prenat Diagn , vol.33 , pp. 630-635
    • Ohno, M.1    Caughey, A.2
  • 34
    • 84880042743 scopus 로고    scopus 로고
    • Maternal cfDNA screening for Down syndrome - A cost-sensitivity analysis
    • H. Cuckle, P. Benn, and E. Pergament Maternal cfDNA screening for Down syndrome - a cost-sensitivity analysis Prenat Diagn 33 2013 636 642
    • (2013) Prenat Diagn , vol.33 , pp. 636-642
    • Cuckle, H.1    Benn, P.2    Pergament, E.3
  • 35
    • 84899508178 scopus 로고    scopus 로고
    • Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service
    • S. Morris, S. Karlsen, and N. Chung Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service PLoS ONE 9 2014 e93559
    • (2014) PLoS ONE , vol.9 , pp. e93559
    • Morris, S.1    Karlsen, S.2    Chung, N.3
  • 37
    • 0028277755 scopus 로고
    • Estimates of the economic costs of birth defects
    • N.J. Waitzman, P.S. Romano, and R.M. Scheffler Estimates of the economic costs of birth defects Inquiry 33 1994 188 205
    • (1994) Inquiry , vol.33 , pp. 188-205
    • Waitzman, N.J.1    Romano, P.S.2    Scheffler, R.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.